🏢 官网IRLXRXCodex · 实盘不做把握 9/10
北京时间·🕒 发布 20:30:34(美东 08:30)·⟳ 抓取 20:33:29 +2m55s·⚡ 决策 07-30 20:34:17 +48s·88.9 天前
Lexicon宣布将于8月6日发布2026年二季度业绩并召开电话会
这只是公司例行披露财报发布日期和电话会安排，未包含业绩数据、指引变化、临床进展或商业化增量。
📄 原文LXRX↗ 原文
Lexicon Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026
THE WOODLANDS, Texas, July 30, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced th…
不做 Lexicon Pharmaceuticals（LXRX.US）
例行财报发布日期和电话会预告，不含业绩、指引、临床或商业化增量，方向中性且无可交易edge。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-30 · 扩散 low · price-in 风险 high ↗
关键理由
- 这只是公司例行披露财报发布日期和电话会安排，未包含业绩数据、指引变化、临床进展或商业化增量。
- 事件本身不改变Lexicon Pharmaceuticals（LXRX.US）的短期收入、利润、管线或融资预期，无法形成同向交易催化。
主要风险
- 真正可交易信息需等2026年8月6日业绩和业务更新正式披露。
原文全文
展开原文 · 1,345 字
THE WOODLANDS, Texas, July 30, 2026 (GLOBE NEWSWIRE) --
Lexicon Pharmaceuticals, Inc.
(Nasdaq: LXRX) today announced the Company will release its second quarter 2026 financial results on Thursday, August 6, 2026, prior to market open. Management will conduct a conference call and live webcast at 8:30 a.m. ET (7:30 a.m. CT) that day to discuss the financial results and to provide a business update.
Participants can access the conference call live via webcast on the Events page of the Company’s website at
https://investors.lexpharma.com/
. Participants who wish to ask a question may
register here
to receive dial-in numbers and a unique pin to join the call. An archived version of the webcast will be available on the Lexicon website.
About Lexicon Pharmaceuticals
Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Lexicon has a pipeline of drug candidates in discovery, preclinical, and clinical development in neuropathic pain, hypertrophic cardiomyopathy (HCM), obesity and metabolic disorders, and other cardiometabolic indications. For additional information, please visit
www.lexpharma.com
.
For Media Inquiries:
Dave Belian
Lexicon Pharmaceuticals, Inc.
lexinvest@lexpharma.com
For Investor Inquiries:
Lisa DeFrancesco
Lexicon Pharmaceuticals, Inc.
lexinvest@lexpharma.com
Lexicon Pharmaceuticals, Inc.
(Nasdaq: LXRX) today announced the Company will release its second quarter 2026 financial results on Thursday, August 6, 2026, prior to market open. Management will conduct a conference call and live webcast at 8:30 a.m. ET (7:30 a.m. CT) that day to discuss the financial results and to provide a business update.
Participants can access the conference call live via webcast on the Events page of the Company’s website at
https://investors.lexpharma.com/
. Participants who wish to ask a question may
register here
to receive dial-in numbers and a unique pin to join the call. An archived version of the webcast will be available on the Lexicon website.
About Lexicon Pharmaceuticals
Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Lexicon has a pipeline of drug candidates in discovery, preclinical, and clinical development in neuropathic pain, hypertrophic cardiomyopathy (HCM), obesity and metabolic disorders, and other cardiometabolic indications. For additional information, please visit
www.lexpharma.com
.
For Media Inquiries:
Dave Belian
Lexicon Pharmaceuticals, Inc.
lexinvest@lexpharma.com
For Investor Inquiries:
Lisa DeFrancesco
Lexicon Pharmaceuticals, Inc.
lexinvest@lexpharma.com
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。